AB012. A phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery (FLAIR) hyperintensity lesion on magnetic resonance image for newly diagnosed supratentorial glioblastoma (JCOG2209)
Yukihiko Sonoda(Yamagata University), Yoshitaka Narita(Unknown), Haruhiko Fukuda(National Cancer Center Hospital East), Koichi Ichimura(Kyorin University), Junki Mizusawa(Japan Clinical Cancer Research Organization), Hiroshi Igaki(National Cancer Centre Japan), Yoshiki Arakawa(Kyoto Prefectural University of Medicine), Tetsuya Sekita(Keio University), Ichiyo Shibahara(Kitasato University), Manabu Kinoshita(Asahikawa Medical University), Mayumi Ichikawa(Yamagata University), Keita Sasaki(Sumitomo Electric Industries (United States)), Yuta Sekino(Japan Clinical Cancer Research Organization), Junji Shibahara(Kyorin University)
Cited by 0
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
|Journal of Thoracic Oncology|2011|656
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial
|Journal of Thoracic and Cardiovascular Surgery|2019|496